Sanofi revenue and financials
In the fiscal year ended December 2025, Sanofi reported revenue of €46.72B (+5.49% year over year). Net income was €7.81B, a net margin of 16.7%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +5.49%
- 2025 vs 2024
- Net income growth
- +40.52%
- 2025 vs 2024
- Net margin
- 16.7%
- 2024: 12.6%
How Sanofi is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 4.6% a year on average over the last 5 years
Compound annual growth rate: from €37.37B in 2020 to €46.72B in 2025.
Revenue has grown for 5 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin fell from 25.2% to 13.6%
Operating income over revenue, 2022 → 2025: 11.6 percentage points.
Profits turn into cash: free cash flow equal to 133% of net income
Totals for fiscal years 2023–2025: free cash flow €24.98B, net income €18.77B.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 46,716 | 44,286 | 41,109 | 40,304 | 39,175 | 37,369 | 37,631 | 35,677 | 36,221 | 34,696 |
| Cost of revenue | 13,049 | 13,205 | 12,628 | 11,882 | 12,255 | 12,159 | 11,979 | 11,435 | 11,613 | 10,701 |
| Gross profit | 33,667 | 31,081 | 28,990 | 28,679 | 26,920 | 25,210 | 25,652 | 24,242 | 24,608 | 23,995 |
| Selling, general and administrative | 9,616 | 9,247 | 9,003 | 8,785 | 9,599 | 9,448 | 9,967 | 9,934 | 10,164 | 9,592 |
| Research and development | 7,842 | 7,394 | 6,507 | 6,501 | 5,692 | 5,530 | 6,020 | 5,894 | 5,472 | 5,172 |
| Operating income | 6,344 | 7,252 | 6,960 | 10,162 | 8,126 | 14,113 | 3,051 | 4,676 | 5,804 | 6,531 |
| EBIT | 9,650 | 8,869 | 8,121 | 10,381 | 8,565 | 7,579 | 6,802 | 6,024 | 7,273 | 7,518 |
| EBITDA | 12,638 | 11,665 | 11,076 | 13,093 | 11,251 | 10,466 | 10,113 | 9,363 | 10,280 | 10,359 |
| Interest expense | 563 | 1,073 | 1,293 | 430 | 368 | 388 | 440 | 435 | 420 | 924 |
| Pre-tax income | 6,020 | 6,758 | 6,115 | 9,992 | 7,837 | 14,137 | 3,007 | 4,904 | 5,616 | 5,811 |
| Income tax | 1,043 | 1,204 | 1,017 | 1,909 | 1,558 | 1,807 | 121 | 481 | 1,722 | 1,325 |
| Net income | 7,813 | 5,560 | 5,400 | 8,371 | 6,223 | 12,294 | 2,754 | 4,306 | 8,416 | 4,709 |
| Net income to common shareholders | 7,813 | 5,560 | 5,400 | 8,371 | 6,223 | 12,294 | 2,855 | 4,319 | 3,773 | 4,395 |
| Basic EPS | 6.40 | 4.44 | 4.31 | 6.69 | 4.97 | 9.82 | 2.24 | 3.45 | 6.70 | 3.66 |
| Diluted EPS | 6.37 | 4.43 | 4.30 | 6.66 | 4.95 | 9.77 | 2.23 | 3.43 | 6.64 | 3.63 |
| Average shares (basic) | 1,220 | 1,251 | 1,252 | 1,252 | 1,253 | 1,254 | 1,250 | 1,247 | 1,257 | 1,287 |
| Average shares (diluted) | 1,226 | 1,256 | 1,256 | 1,257 | 1,258 | 1,260 | 1,257 | 1,255 | 1,267 | 1,296 |
| Dividend per share | 4.12 | 3.92 | 3.76 | 3.56 | 3.33 | 3.20 | 3.15 | 3.07 | 3.03 | 2.96 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15,233 | 12,300 | 11,244 | 12,205 | 13,170 | 10,735 | 10,606 | — | 14,157 | — | 11,118 | — |
| Cost of revenue | 3,632 | 2,889 | 3,056 | 3,630 | 3,412 | 2,992 | 2,889 | — | 4,085 | — | 3,439 | — |
| Gross profit | 11,601 | 9,411 | 8,188 | 8,575 | 9,758 | 7,743 | 7,717 | — | 10,072 | — | 7,679 | — |
| Selling, general and administrative | 2,309 | 2,492 | 2,327 | 2,819 | 2,291 | 2,321 | 2,222 | — | 2,681 | — | 2,605 | — |
| Research and development | 1,849 | 2,233 | 1,747 | 2,291 | 1,834 | 1,909 | 1,808 | — | 1,852 | — | 1,719 | — |
| Operating income | 4,705 | 2,587 | 2,249 | 1,740 | 3,784 | 1,712 | 2,424 | — | 4,079 | — | 2,032 | — |
| EBIT | 4,705 | 2,587 | 2,249 | 1,740 | 3,784 | 1,712 | 2,424 | — | 4,079 | — | 2,032 | — |
| EBITDA | 5,677 | 3,826 | 2,784 | 3,490 | 4,197 | 2,533 | 3,172 | — | 4,909 | — | 2,862 | — |
| Interest expense | 222 | 153 | 138 | 38.0 | 227 | 62.0 | 154 | — | 265 | — | 253 | — |
| Pre-tax income | 4,224 | 828 | 2,014 | -1,155 | 3,508 | 1,467 | 2,200 | — | 3,581 | — | 1,310 | — |
| Income tax | 1,195 | 451 | 420 | -348 | 680 | 230 | 481 | — | 737 | — | 164 | — |
| Net income | 3,021 | 343 | 1,614 | -801 | 2,802 | 3,940 | 1,872 | — | 2,815 | — | 1,133 | — |
| Net income to common shareholders | 3,021 | 343 | 1,614 | -801 | 2,802 | 3,940 | 1,872 | — | 2,815 | — | 1,133 | — |
| Basic EPS | 2.52 | 0.29 | 1.34 | -0.66 | 2.30 | 3.24 | 1.52 | — | 2.25 | — | 0.91 | — |
| Diluted EPS | 2.52 | 0.28 | 1.34 | -0.66 | 2.30 | 3.23 | 1.52 | — | 2.25 | — | 0.91 | — |
| Average shares (basic) | 1,200 | 1,197 | 1,204 | 1,213 | 1,218 | 1,217 | 1,234 | — | 1,253 | — | 1,249 | — |
| Average shares (diluted) | 1,200 | 1,197 | 1,204 | 1,213 | 1,218 | 1,217 | 1,234 | — | 1,253 | — | 1,249 | — |
| Dividend per share | — | — | — | 4.12 | — | — | — | — | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 126,805 | 132,798 | 126,464 | 126,722 | 120,242 | 114,413 | 112,630 | 111,408 | 99,813 | 104,679 |
| Current assets | 30,952 | 42,588 | 30,670 | 34,111 | 30,653 | 33,786 | 28,936 | 24,647 | 26,388 | 33,112 |
| Cash and equivalents | 7,657 | 7,441 | 8,710 | 12,736 | 10,098 | 13,915 | 9,427 | 6,925 | 10,315 | 10,273 |
| Short-term investments | 810 | 486 | 270 | 663 | — | — | — | — | — | — |
| Receivables | 11,046 | 10,629 | 11,040 | 10,747 | 9,787 | 9,953 | 10,083 | 9,345 | 7,843 | 8,016 |
| Inventory | 10,214 | 9,431 | 9,666 | 8,960 | 8,715 | 8,352 | 7,994 | 7,477 | 6,818 | 6,896 |
| Net property, plant and equipment | 11,511 | 11,601 | 11,814 | 11,684 | 11,976 | 10,563 | 11,017 | 9,651 | 9,579 | 10,019 |
| Goodwill | 41,300 | 43,384 | 49,404 | 49,892 | 48,056 | 44,364 | 44,519 | 44,235 | 40,264 | 40,287 |
| Other intangible assets | 17,530 | 14,260 | 18,281 | 15,414 | 13,677 | 12,249 | 14,175 | 17,145 | 11,605 | 9,520 |
| Long-term investments | 6,854 | 3,259 | 2,666 | 2,765 | 2,422 | 2,105 | 5,266 | 5,531 | 5,379 | 2,892 |
| Current liabilities | 28,345 | 29,162 | 24,207 | 23,974 | 21,295 | 19,280 | 20,387 | 17,376 | 15,463 | 17,638 |
| Accounts payable | 7,361 | 7,551 | 7,328 | 6,813 | 6,180 | 5,295 | 5,313 | 5,041 | 4,633 | 4,297 |
| Long-term debt | 18,702 | 16,137 | 16,531 | 19,218 | 20,250 | 22,631 | 24,568 | 24,586 | 15,468 | 18,509 |
| Total debt | 20,170 | 17,713 | 18,220 | 21,048 | 22,226 | 23,390 | 25,628 | 24,371 | 15,364 | 18,378 |
| Total liabilities | 55,095 | 54,941 | 52,111 | 51,570 | 51,211 | 51,161 | 53,400 | 52,373 | 41,574 | 46,957 |
| Total equity (incl. minority) | 71,710 | 77,857 | 74,353 | 75,152 | 69,031 | 63,252 | 59,230 | 59,035 | 58,239 | 57,722 |
| Minority interest | 334 | 350 | 313 | 368 | 350 | 146 | 174 | 159 | 169 | 170 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 130,287 | 129,060 | 128,024 | 126,805 | 129,794 | 124,959 | 131,892 | 132,798 | — | 129,755 | — | 126,464 |
| Current assets | 33,207 | 31,522 | 30,164 | 30,952 | 34,042 | 37,017 | 44,019 | 42,588 | — | 30,081 | — | 30,670 |
| Cash and equivalents | 5,966 | 6,350 | 5,544 | 7,657 | 8,906 | 15,359 | 7,991 | 7,441 | — | 6,795 | — | 8,710 |
| Short-term investments | — | — | — | 810 | — | — | — | — | — | — | — | — |
| Receivables | 326 | 9,206 | 482 | 11,046 | 497 | 8,207 | 447 | 10,629 | — | 8,805 | — | 11,040 |
| Inventory | 25,023 | 11,127 | 23,503 | 10,214 | 24,501 | 9,618 | 21,850 | 9,431 | — | 10,609 | — | 9,666 |
| Net property, plant and equipment | 12,076 | 11,954 | 11,674 | 11,511 | 11,181 | 11,007 | 11,352 | 11,601 | — | 11,880 | — | 11,814 |
| Goodwill | — | 41,954 | — | 41,300 | — | 40,283 | — | 43,384 | — | 50,080 | — | 49,404 |
| Other intangible assets | 67,626 | 18,333 | 69,086 | 17,530 | 68,867 | 12,383 | 63,809 | 14,260 | — | 18,123 | — | 18,281 |
| Long-term investments | — | 7,104 | — | 6,854 | — | 6,995 | — | 3,259 | — | 2,640 | — | 2,666 |
| Current liabilities | 29,767 | 31,930 | 30,008 | 28,345 | 32,105 | 29,059 | 32,221 | 29,162 | — | 30,027 | — | 24,207 |
| Accounts payable | 24,553 | 7,150 | 22,708 | 7,361 | 22,000 | 7,075 | 21,616 | 7,551 | — | 7,433 | — | 7,328 |
| Long-term debt | 14,593 | 14,646 | 12,298 | 14,329 | 11,700 | 13,200 | 11,767 | 11,791 | — | 12,503 | — | 14,347 |
| Total debt | 16,496 | 23,441 | 14,100 | 20,170 | 13,553 | 22,146 | 13,676 | 17,713 | — | 16,581 | — | — |
| Total liabilities | 57,046 | 59,493 | 54,881 | 55,095 | 56,261 | 54,680 | 57,474 | 54,941 | — | 56,758 | — | 52,111 |
| Total equity (incl. minority) | 73,241 | 69,567 | 73,143 | 71,710 | 73,533 | 70,279 | 74,418 | 77,857 | 72,997 | 72,997 | 74,353 | 74,353 |
| Minority interest | 362 | 360 | 335 | 334 | 270 | 271 | 344 | 350 | — | 307 | — | 313 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10,750 | 9,081 | 10,258 | 10,526 | 10,522 | 7,418 | 7,715 | 5,547 | 7,379 | 7,838 |
| Depreciation and amortization | 3,257 | 3,111 | 3,247 | 3,053 | 3,001 | 3,186 | 3,593 | 3,339 | 3,007 | 2,841 |
| Capital expenditure | -1,762 | -1,733 | -1,619 | -1,529 | -1,478 | -1,254 | -1,323 | -1,415 | -1,388 | -1,219 |
| Investing cash flow | -2,447 | -4,407 | -6,200 | -2,075 | -7,298 | 3,619 | -1,183 | -12,866 | -2,896 | -2,511 |
| Financing cash flow | -8,207 | -5,763 | -8,052 | -5,821 | -7,056 | -6,485 | -4,039 | 3,928 | -4,367 | -4,101 |
| Dividends paid | -4,772 | -4,704 | -4,454 | -4,168 | -4,008 | -3,937 | -3,834 | -3,773 | -3,710 | -3,759 |
| Share repurchases | -5,030 | -302 | -593 | -497 | -382 | -822 | -9.0 | -1,101 | -2,162 | -2,908 |
| Debt issued | 5,559 | 59.0 | 799 | 1,765 | — | 2,301 | 1,997 | 9,677 | 71.0 | 4,869 |
| Debt repaid | -4,055 | -953 | -3,936 | -2,998 | -2,804 | -4,186 | -2,488 | -955 | -2,368 | -2,576 |
| Effect of exchange rates | -47.0 | -13.0 | -32.0 | 8.0 | 15.0 | -64.0 | 9.0 | 1.0 | -74.0 | -101 |
| Net change in cash | 216 | -1,269 | -4,026 | 2,638 | -3,817 | 4,488 | 2,502 | -3,390 | 42.0 | 1,125 |
| Free cash flow | 8,988 | 7,348 | 8,639 | 8,997 | 9,044 | — | — | — | — | — |
| Levered free cash flow | 16,643 | -4,944 | 7,172 | 8,514 | 7,336 | 6,284 | 5,110 | 4,168 | 10,834 | 5,747 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3,871 | 2,960 | 1,683 | 3,445 | 3,750 | 1,462 | 2,093 | — | — |
| Depreciation and amortization | 972 | 1,239 | 535 | 2,019 | -279 | 821 | 748 | — | — |
| Capital expenditure | -630 | -882 | — | -1,762 | 845 | -845 | — | — | — |
| Investing cash flow | -541 | -365 | -2,278 | -2,131 | -9,043 | 9,503 | -776 | — | — |
| Financing cash flow | -3,713 | -1,805 | -1,527 | -2,570 | -1,148 | -3,897 | -592 | — | — |
| Dividends paid | 0.0 | -4,923 | — | -4,772 | — | -4,772 | — | — | — |
| Share repurchases | -18.0 | -1,009 | — | -5,030 | -29.0 | -4,003 | — | — | — |
| Debt issued | -4,259 | 4,259 | — | 5,559 | -6,315 | 6,315 | — | — | — |
| Debt repaid | 1,652 | -1,652 | — | -4,055 | 1,983 | -1,983 | — | — | — |
| Effect of exchange rates | -1.0 | 10.0 | 9.0 | 7.0 | -12.0 | -22.0 | -20.0 | — | — |
| Net change in cash | -384 | 800 | -2,113 | -1,249 | -6,453 | 7,367 | 551 | — | — |
| Free cash flow | 3,241 | 2,078 | 1,683 | 1,683 | 4,595 | 617 | 2,093 | — | — |
| Levered free cash flow | 2,282 | 2,004 | 608 | 1,967 | 1,952 | 11,886 | 1,071 | — | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
